Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

EU recommendations for Gilead, Ariad and Baxter drugs

EMA backs use of HyQvia, Iclusig and Stribild

- PMLiVE

CHMP backs oral MS drugs from Sanofi, Biogen Idec

Tecfidera and Aubagio recommended for use in Europe

- PMLiVE

Takeda files lymphoma drug brentuximab vedotin in Japan

Seeks approval for antibody-drug conjugate for two forms of the blood cancer

- PMLiVE

PAN hires new senior copywriter and account manager

Sarah White and Rachel Flavell move from Ogilvy Healthworld and Cherry, respectively

GSK’s rare diseases head Marc Dunoyer to join AZ

Appointed executive VP, global portfolio and product strategy amid global restructure

- PMLiVE

Otsuka’s Pletal has use restricted in Europe

EMA recommends drug only be used in limited group of patients with blood supply disorder

- PMLiVE

This month in 1980: 33 years since cyclosporine demonstrated its potential as an immunosuppressant

This month in 1980: How organ transplantation was transformed by cyclosporine

Vivus launches weight loss app to swell Qsymia sales

iPhone and Android Q and Me app backed up with patient support programme

Sanofi reception

Follow-up data suggests long-term benefit of Sanofi’s Lemtrada in MS

Drug has a durable effect on relapse rates and disability progression

- PMLiVE

NICE will take central role in UK’s value-based pricing system

DH confirms role of cost-effectiveness watchdog in drug reimbursement plans from 2014

- PMLiVE

Takeda suspended as vice president of Japanese industry body

Mis-labelling also prompts JPMA to takes action against CMO Nihon Pharmaceutical

Changes at several UK health bodies

Round-up of recent Department of Health appointments

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links